没有数据	没有数据

没有数据	没有数据

来源	SDS样本
Sigma-Aldrich	浏览或下载
Oakwood	浏览或下载
Matrix	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.Luke S Uebelhoer et al.Antiviral research, 106, 86-94 (2014-04-10) Sofosbuvir and ribavirin in HCV genotypes 2 and 3.Stefan Zeuzem et al.The New England journal of medicine, 370(21), 1993-2001 (2014-05-06) Randomized trial of peginterferon alpha-2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1.Yoshiaki Iwasaki et al.Journal of medical virology, 87(4), 625-633 (2015-01-23) Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate.Laurent Volpon et al.Biochemical and biophysical research communications, 434(3), 614-619 (2013-04-16) Sofosbuvir for previously untreated chronic hepatitis C infection.Eric Lawitz et al.The New England journal of medicine, 369(7), 678-679 (2013-08-16) Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.M Colombo et al.Gut, 63(7), 1150-1158 (2013-11-10) Yakammaoto inhibits enterovirus 71 infection by reducing viral attachment, internalization, replication, and translation.Chia-Feng Yeh et al.The Kaohsiung journal of medical sciences, 31(6), 293-302 (2015-06-05) Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.Eric Lawitz et al.Lancet (London, England), 383(9916), 515-523 (2013-11-12) The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis.Jun-Ying Liu et al.Virology journal, 9, 186-186 (2012-09-07) Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.Ekram W Abd El-Wahab et al.Journal of medical virology, 87(3), 428-440 (2015-01-15) Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR.Giuseppe Bruno et al.The new microbiologica, 38(1), 21-27 (2015-03-06) Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence.Jianxiong Zeng et al.Journal of virology, 88(8), 4008-4020 (2014-01-24) Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C.Mahdiyar Pouresmaeeli et al.Hepatitis monthly, 15(9), e30780-e30780 (2015-10-28) Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C.Susanne Sarkar et al.The British journal of psychiatry : the journal of mental science, 206(1), 45-51 (2014-11-02) Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C.Guido Stirnimann Expert opinion on pharmacotherapy, 15(17), 2609-2622 (2014-10-28) Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients.Shaimuna Fareeha Sajjad et al.JPMA. The Journal of the Pakistan Medical Association, 62(11), 1229-1232 (2013-07-23) Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.Emanuel Raschi et al.British journal of clinical pharmacology, 80(2), 285-293 (2015-02-18) Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma--A retrospective multicenter study.Naoki Harada et al.Journal of medical virology, 87(7), 1199-1206 (2015-03-17) Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis.Qianqian Zhu et al.Antiviral research, 98(3), 373-379 (2013-04-23) Editorial: can we afford the new direct-acting antivirals for treatment of genotype 1 hepatitis C?S E Congly et al.Alimentary pharmacology & therapeutics, 40(8), 983-984 (2014-09-18) Quantum leaps, microeconomics, and the treatment of patients with hepatitis C and HIV coinfection.Michael S Saag JAMA, 312(4), 347-348 (2014-07-20) The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.Hiba Ahmad Zahreddine et al.Nature, 511(7507), 90-93 (2014-05-30) Baseline factors associated with treatment response in patients infected with hepatitis C virus 1b by stratification of IL28B polymorphisms.Qihua Ling et al.Archives of virology, 160(4), 1105-1112 (2015-02-18) The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis.Michael P Manns et al.Gastroenterology, 147(2), 366-376 (2014-04-15) Monocyte activation by interferon α is associated with failure to achieve a sustained virologic response after treatment for hepatitis C virus infection.Dennis J Hartigan-O'Connor et al.The Journal of infectious diseases, 209(10), 1602-1612 (2013-12-12) Controlling hepatitis C with simeprevir.Geoffrey Dusheiko The Lancet. Infectious diseases, 15(1), 2-4 (2014-12-09) Mutations in coronavirus nonstructural protein 10 decrease virus replication fidelity.Everett Clinton Smith et al.Journal of virology, 89(12), 6418-6426 (2015-04-10) Validity of aspartate aminotransferase to platelet ratio index as predictor of early viral response in patients with hepatitis C treated by interferon-based therapy.Shaikh Samiullah et al.JPMA. The Journal of the Pakistan Medical Association, 62(10), 1008-1011 (2013-07-23) In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance.Inge Vliegen et al.Antiviral research, 120, 112-121 (2015-06-04) Sequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in Mosquitoes.Greta A Van Slyke et al.PLoS pathogens, 11(6), e1005009-e1005009 (2015-06-27) In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance.Inge Vliegen et al.Antiviral research, 120, 112-121 (2015-06-04) Validity of aspartate aminotransferase to platelet ratio index as predictor of early viral response in patients with hepatitis C treated by interferon-based therapy.Shaikh Samiullah et al.JPMA. The Journal of the Pakistan Medical Association, 62(10), 1008-1011 (2013-07-23) Sequence-Specific Fidelity Alterations Associated with West Nile Virus Attenuation in Mosquitoes.Greta A Van Slyke et al.PLoS pathogens, 11(6), e1005009-e1005009 (2015-06-27) High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.Luke S Uebelhoer et al.Antiviral research, 106, 86-94 (2014-04-10) Randomized trial of peginterferon alpha-2b plus low and escalating dose of ribavirin in patients with chronic hepatitis C with high viral load genotype 1.Yoshiaki Iwasaki et al.Journal of medical virology, 87(4), 625-633 (2015-01-23) Yakammaoto inhibits enterovirus 71 infection by reducing viral attachment, internalization, replication, and translation.Chia-Feng Yeh et al.The Kaohsiung journal of medical sciences, 31(6), 293-302 (2015-06-05) Conformational changes induced in the eukaryotic translation initiation factor eIF4E by a clinically relevant inhibitor, ribavirin triphosphate.Laurent Volpon et al.Biochemical and biophysical research communications, 434(3), 614-619 (2013-04-16) The combination of MK-5172, peginterferon, and ribavirin is effective in treatment-naive patients with hepatitis C virus genotype 1 infection without cirrhosis.Michael P Manns et al.Gastroenterology, 147(2), 366-376 (2014-04-15) Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.Eric Lawitz et al.Lancet (London, England), 383(9916), 515-523 (2013-11-12) Sofosbuvir for previously untreated chronic hepatitis C infection.Eric Lawitz et al.The New England journal of medicine, 369(7), 678-679 (2013-08-16) Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.M Colombo et al.Gut, 63(7), 1150-1158 (2013-11-10) Side effects of antiviral therapy in hepatitis C virus infection-sarcoidosis - case report.D Teodor et al.Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi, 116(4), 1039-1043 (2013-05-25) Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.Tim J Benstead et al.The Cochrane database of systematic reviews, 12(12), CD010404-CD010404 (2014-12-20) Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patients.Cristina Novembrino et al.Journal of viral hepatitis, 21(12), 944-949 (2014-07-22) Modeling viral kinetics and treatment outcome during alisporivir interferon-free treatment in hepatitis C virus genotype 2 and 3 patients.Jeremie Guedj et al.Hepatology (Baltimore, Md.), 59(5), 1706-1714 (2014-01-01) Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.Simone Susser et al.PloS one, 9(11), e112592-e112592 (2014-11-14) Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.Kim Long Yeo et al.Antimicrobial agents and chemotherapy, 59(4), 2086-2093 (2015-01-28) Reply: To PMID 24449403.Jacinta A Holmes et al.Hepatology (Baltimore, Md.), 61(1), 409-409 (2014-06-12) The Intrahepatic T Cell Compartment Does Not Normalize Years After Therapy-Induced Hepatitis C Virus Eradication.Michelle Spaan et al.The Journal of infectious diseases, 212(3), 386-390 (2015-02-01) Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.Ira M Jacobson et al.Lancet (London, England), 384(9941), 403-413 (2014-06-08) Ribavirin enhances myeloid-derived suppressor cell differentiation through CXCL9/10 downregulation.Jingyin Dong et al.Immunopharmacology and immunotoxicology, 36(6), 412-419 (2014-09-26) Novel composed galactosylated nanodevices containing a ribavirin prodrug as hepatic cell-targeted carriers for HCV treatment.Emanuela Fabiola Craparo et al.Journal of biomedical nanotechnology, 9(6), 1107-1122 (2013-07-19) Pretreatment serum macrophage inflammatory protein (MIP)-1 levels predict sustained virological responses to re-treatment in patients with chronic hepatitis C virus infection.Shibin Zhang et al.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 33, 15-21 (2014-12-03) Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.Mark S Sulkowski et al.The New England journal of medicine, 370(3), 211-221 (2014-01-17) Genotype-Associated Differential NKG2D Expression on CD56+CD3+ Lymphocytes Predicts Response to Pegylated-Interferon/Ribavirin Therapy in Chronic Hepatitis C.Po-sung Chu et al.PloS one, 10(5), e0125664-e0125664 (2015-05-13) Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.Michael Charlton et al.Gastroenterology, 148(1), 108-117 (2014-10-12) Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.Zobair Younossi et al.Hepatology (Baltimore, Md.), 58(6), 1897-1906 (2014-01-03) [Immunogenetic factors of interaction of hepatitis C virus and human and possibilities of development of therapeutic tactic].N V Fedoseeva et al.Zhurnal mikrobiologii, epidemiologii, i immunobiologii, (3)(3), 97-103 (2013-09-05) Association between response to pegylated interferon/ribavirin therapy and ribavirin levels.Chia-Yen Dai et al.Hepatology (Baltimore, Md.), 61(1), 408-409 (2014-04-23) An antiviral drug screening system for enterovirus 71 based on an improved plaque assay: A potential high-throughput method.Yingxian Yin et al.Journal of medical virology, 91(8), 1440-1447 (2019-03-23) Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection.Jun Hou et al.Journal of virology, 88(21), 12254-12264 (2014-08-08) Genetic Variability of Hepatitis C Virus (HCV) 5' Untranslated Region in HIV/HCV Coinfected Patients Treated with Pegylated Interferon and Ribavirin.Iwona Bukowska-Ośko et al.PloS one, 10(5), e0125604-e0125604 (2015-05-02) An interferon-free antiviral regimen for HCV after liver transplantation.Paul Y Kwo et al.The New England journal of medicine, 371(25), 2375-2382 (2014-11-12) Vaccine-derived mutation in motif D of poliovirus RNA-dependent RNA polymerase lowers nucleotide incorporation fidelity.Xinran Liu et al.The Journal of biological chemistry, 288(45), 32753-32765 (2013-10-03) Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines.Rand R Hafidh et al.BMC complementary and alternative medicine, 15, 179-179 (2015-06-13) The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis.Jun-Ying Liu et al.Virology journal, 9, 186-186 (2012-09-07) Insulin resistance as a predictor of early virologic response to HCV therapy among chronic HCV Egyptian patients.Ekram W Abd El-Wahab et al.Journal of medical virology, 87(3), 428-440 (2015-01-15) Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence.Jianxiong Zeng et al.Journal of virology, 88(8), 4008-4020 (2014-01-24) Real life experience in treatment of HIV-1/HCV-coinfected patients with pegylated interferon alpha and ribavirin: predictors of SVR.Giuseppe Bruno et al.The new microbiologica, 38(1), 21-27 (2015-03-06) Serum proteome predicts virological response in chronic hepatitis C genotype 1b patients treated with pegylated interferon plus ribavirin.Yi-Hao Yen et al.Journal of the Formosan Medical Association = Taiwan yi zhi, 114(7), 652-658 (2013-07-03) Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector.Guido Wollmann et al.Virology, 475, 1-14 (2014-12-03) Efficacy and Tolerability of Peginterferon alpha-2a and Peginterferon alpha-2b in Iranian Patients With Chronic Hepatitis C.Mahdiyar Pouresmaeeli et al.Hepatitis monthly, 15(9), e30780-e30780 (2015-10-28) Therapeutic potential of antiviral drugs targeting chemorefractory colorectal adenocarcinoma cells overexpressing endogenous retroviral elements.David Díaz-Carballo et al.Journal of experimental & clinical cancer research : CR, 34, 81-81 (2015-08-12) Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C.Susanne Sarkar et al.The British journal of psychiatry : the journal of mental science, 206(1), 45-51 (2014-11-02) Editorial: can we afford the new direct-acting antivirals for treatment of genotype 1 hepatitis C?S E Congly et al.Alimentary pharmacology & therapeutics, 40(8), 983-984 (2014-09-18) Quantum leaps, microeconomics, and the treatment of patients with hepatitis C and HIV coinfection.Michael S Saag JAMA, 312(4), 347-348 (2014-07-20) The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.Hiba Ahmad Zahreddine et al.Nature, 511(7507), 90-93 (2014-05-30) HCV therapy with daclatasvir, PEG-IFN, and RBV after boceprevir-based therapy failure post-liver transplantation in hyper-IgM syndrome.K Rajender Reddy et al.Transplantation, 97(8), e47-e48 (2014-04-16) Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.Michael Manns et al.Lancet (London, England), 384(9941), 414-426 (2014-06-08) Ombitasvir (ABT-267), a novel NS5A inhibitor for the treatment of hepatitis C.Guido Stirnimann Expert opinion on pharmacotherapy, 15(17), 2609-2622 (2014-10-28) Weight loss with interferon and ribavirin therapy in chronic hepatitis C patients.Shaimuna Fareeha Sajjad et al.JPMA. The Journal of the Pakistan Medical Association, 62(11), 1229-1232 (2013-07-23) Liver injury with novel oral anticoagulants: assessing post-marketing reports in the US Food and Drug Administration adverse event reporting system.Emanuel Raschi et al.British journal of clinical pharmacology, 80(2), 285-293 (2015-02-18) A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin.Ching-Sheng Hsu et al.Journal of the Formosan Medical Association = Taiwan yi zhi, 113(10), 716-721 (2014-06-30) Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma--A retrospective multicenter study.Naoki Harada et al.Journal of medical virology, 87(7), 1199-1206 (2015-03-17) Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis.Qianqian Zhu et al.Antiviral research, 98(3), 373-379 (2013-04-23) Update on combinations of DAAs with and without pegylated-interferon and ribavirin: triple and quadruple therapy more than doubles SVR.Valérie Martel-Laferrière et al.Clinics in liver disease, 17(1), 93-103 (2012-11-28) Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.Michael Köhler et al.BMJ (Clinical research ed.), 350, h796-h796 (2015-02-28) Ribavirin dose reduction during telaprevir/ribavirin/peg-interferon therapy overcomes the effect of the ITPA gene polymorphism.S Akamatsu et al.Journal of viral hepatitis, 22(2), 166-174 (2014-06-17) Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.Graham R Foster et al.Gastroenterology, 149(6), 1462-1470 (2015-08-08) An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors.Irina C Albulescu et al.The Journal of general virology, 95(Pt 12), 2683-2692 (2014-08-20) In vitro activity and resistance profile of samatasvir, a novel NS5A replication inhibitor of hepatitis C virus.J P Bilello et al.Antimicrobial agents and chemotherapy, 58(8), 4431-4442 (2014-05-29) Ribavirin inhibits Chandipura virus replication in Vero cells.Anukumar Balakrishnan et al.Journal of medical virology (2020-06-17) Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver.Zhongqi Dong et al.Journal of pharmaceutical sciences, 104(9), 2864-2876 (2015-02-04) Neurocognitive function and dysfunction after hepatitis C therapy.Pablo Solis-Muñoz et al.Hepatology (Baltimore, Md.), 60(1), 431-431 (2013-11-02) Atazanavir-based therapy with pegylated interferon and ribavirin for patients with hepatitis C and HIV.Antonio Rivero-Juarez et al.The Lancet. Infectious diseases, 14(1), 13-14 (2013-12-21) Virus uncoating is required for apoptosis induction in cultured mammalian cells infected with African horse sickness virus.Elaine Vermaak et al.The Journal of general virology, 96(Pt 7), 1811-1820 (2015-03-19) Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals.Liesl M Hagan et al.Hepatology (Baltimore, Md.), 60(1), 37-45 (2014-03-29) Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.Liwei An et al.Antiviral research, 109, 54-63 (2014-06-28) Comparative effectiveness of telaprevir-based triple therapy in patients with chronic hepatitis C.Badr Al-Bawardy et al.Mayo Clinic proceedings, 89(5), 595-601 (2014-03-26) DRESS syndrome with suspected Strongyloides infection in a patient treated for hepatitis C.Lahari Rampur et al.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 111(2), 138-139 (2013-07-28) Attenuation of human enterovirus 71 high-replication-fidelity variants in AG129 mice.Tao Meng et al.Journal of virology, 88(10), 5803-5815 (2014-03-14) Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.Michael P Curry et al.Gastroenterology, 148(1), 100-107 (2014-09-28) High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses.Rajini Mudhasani et al.PLoS neglected tropical diseases, 8(8), e3095-e3095 (2014-08-22) Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.Stefan Zeuzem et al.The New England journal of medicine, 370(17), 1604-1614 (2014-04-12) [Study on effect of intensive treatment for refractory chronic hepatitis C patients].Ming-Hui Li et al.Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology, 26(5), 374-378 (2013-04-04) Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy.A J Khan et al.Epidemiology and infection, 143(1), 71-80 (2014-03-20) Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis.Filippa Pettersson et al.Cancer research, 75(6), 1102-1112 (2015-01-23) [Hepatitis C virus: 25 years-old, the end?].Stanislas Pol Medecine sciences : M/S, 29(11), 998-1003 (2013-11-28) Uptake and utilization of directly acting antiviral medications for hepatitis C infection in U.S. veterans.R Gidwani et al.Journal of viral hepatitis, 22(5), 489-495 (2014-11-25) All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection.David L Wyles et al.Hepatology (Baltimore, Md.), 60(1), 56-64 (2014-02-07) In vitro anti-influenza virus activities of a new lignan glycoside from the latex of Calotropis gigantea.Supawadee Parhira et al.PloS one, 9(8), e104544-e104544 (2014-08-08) HCV-specific CD8+ cell detection at week 12 of chronic hepatitis C treatment with PEG-interferon-α2b/ribavirin correlates with infection resolution.Juan-Ramón Larrubia et al.Cellular immunology, 286(1-2), 31-38 (2013-11-30) Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection.Katerina Tsilika et al.JAMA dermatology, 149(6), 675-677 (2013-04-05) OPERA: use of pegylated interferon plus ribavirin for treating HCV-HIV coinfection in interferon-naive patients.Giampiero Carosi et al.Antiviral therapy, 19(8), 735-745 (2014-03-04) Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.Jessica Y Rathbun et al.Journal of virology, 89(16), 8428-8443 (2015-06-05) Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.Tove C Bolken et al.Antiviral research, 69(2), 86-97 (2005-12-14) Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques.Darryl Falzarano et al.Nature medicine, 19(10), 1313-1317 (2013-09-10) Antiviral and antitumor activities of the lectin extracted from Aspidistra elatior.Xiao-Chao Xu et al.Zeitschrift fur Naturforschung. C, Journal of biosciences, 70(1-2), 7-13 (2015-04-10) [HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy].K Herzer et al.Deutsche medizinische Wochenschrift (1946), 138(36), 1759-1764 (2013-09-05) Re-treatment with highly purified nIFNα in Mexican nonresponder patients with chronic genotype 1 hepatitis C.Linda E Muñoz-Espinosa et al.Archives of medical research, 44(6), 444-448 (2013-09-21) [HCV reinfection after liver transplantation - management and first experiences with telaprevir-based triple therapy].K Herzer et al.Deutsche medizinische Wochenschrift (1946), 138(36), 1759-1764 (2013-09-05) Anti-respiratory syncytial virus prenylated dihydroquinolone derivatives from the gorgonian-derived fungus Aspergillus sp. XS-20090B15.Min Chen et al.Journal of natural products, 77(12), 2720-2724 (2014-11-25) Antiviral activity of Paulownia tomentosa against enterovirus 71 of hand, foot, and mouth disease.Ping Ji et al.Biological & pharmaceutical bulletin, 38(1), 1-6 (2015-03-07) [Therapy of chronic hepatitis C].Stella Schaffstein et al.Praxis, 103(8), 423-436 (2014-04-10) Association of interleukin-10 polymorphisms with chronic hepatitis C virus infection in a case-control study and its effect on the response to combined pegylated interferon/ribavirin therapy.A J Khan et al.Epidemiology and infection, 143(1), 71-80 (2014-03-20) Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.Michael P Curry et al.Gastroenterology, 148(1), 100-107 (2014-09-28) Preclinical evaluation of GS-9160, a novel inhibitor of human immunodeficiency virus type 1 integrase.Gregg S Jones et al.Antimicrobial agents and chemotherapy, 53(3), 1194-1203 (2008-12-24) Ribavirin with interferon for hepatitis C in dialysis patients: efficacious and safe in the right patients in good hands.David Mutimer Gut, 64(2), 190-191 (2014-05-28) Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response.Saleha Resham et al.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 123(9), 765-771 (2015-07-17) Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.W Markland et al.Antimicrobial agents and chemotherapy, 44(4), 859-866 (2000-03-18) Pharmacokinetics and pharmacodynamics of setrobuvir, an orally administered hepatitis C virus non-nucleoside analogue inhibitor.Navita L Mallalieu et al.Clinical therapeutics, 36(12), 2047-2063 (2014-12-03) Carbon nanotube-based nanocarrier loaded with ribavirin against grass carp reovirus.Bin Zhu et al.Antiviral research, 118, 29-38 (2015-03-24) A non-interventional phase IV Belgian survey to assess the antiviral effectiveness of pegylated interferon-alpha-2b and ribavirin treatment according to the stage of liver fibrosis in previously untreated patients with genotype 1/4/5/6 chronic hepatitis C (PRACTICE).S Bourgeois et al.Acta gastro-enterologica Belgica, 77(4), 393-400 (2015-02-17) Ischemic colitis during interferon-ribavirin therapy for chronic hepatitis C: a case report.Su Jung Baik et al.World journal of gastroenterology, 18(31), 4233-4236 (2012-08-25) Effective lethal mutagenesis of influenza virus by three nucleoside analogs.Matthew D Pauly et al.Journal of virology, 89(7), 3584-3597 (2015-01-16) Sofosbuvir for previously untreated chronic hepatitis C infection.Eric Lawitz et al.The New England journal of medicine, 368(20), 1878-1887 (2013-04-24) Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: a metabolomics analysis.Takafumi Saito et al.Metabolism: clinical and experimental, 62(11), 1577-1586 (2013-08-21) The price of good health. Nature medicine, 20(4), 319-319 (2014-04-09) Response of Black African patients with hepatitis C virus genotype 4 to treatment with peg-interferon and ribavirin.M Nkuize et al.Acta gastro-enterologica Belgica, 76(3), 291-299 (2013-11-23) Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin.Chansoo Moon et al.Digestive diseases and sciences, 60(2), 573-581 (2014-09-23) Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.Chen-Hua Liu et al.Annals of internal medicine, 159(11), 729-738 (2013-12-04) Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US.Sai Zhang et al.BMC gastroenterology, 15, 98-98 (2015-08-05) Tuberculous peritonitis during pegylated interferon plus ribavirin combination therapy in a patient with chronic hepatitis C.Ryohei Fukuba et al.Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 111(12), 2337-2345 (2014-12-09) Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial.Christophe Hézode et al.Lancet (London, England), 385(9986), 2502-2509 (2015-04-04) Mycophenolic acid is a drug with the potential to be repurposed for suppressing tumor growth and metastasis in osteosarcoma treatment.Jeerawan Klangjorhor et al.International journal of cancer, 146(12), 3397-3409 (2019-10-15) Beyond phase 3 registration trials: defining safety for triple therapy with protease inhibitors in cirrhosis.P Ferenci et al.Gut, 63(7), 1033-1034 (2013-12-18) Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis.Kris V Kowdley et al.The New England journal of medicine, 370(20), 1879-1888 (2014-04-12) Triple therapy for hepatitis C virus infection in patients receiving hemodialysis.Sara Lemoinne et al.Annals of internal medicine, 160(8), 581-581 (2014-04-16) Managing adverse effects of interferon-alfa and ribavirin in combination therapy for HCV.Jihad Slim et al.Infectious disease clinics of North America, 26(4), 917-929 (2012-10-23) Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C.K Rutter et al.Alimentary pharmacology & therapeutics, 41(6), 521-531 (2015-01-24) Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis.Marcela Pezzoto Laurito et al.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 17(5), 555-563 (2013-09-24) Treatment indication and response to standard of care with peginterferon and ribavirin in acute and chronic HCV infection.Jordan J Feld Best practice & research. Clinical gastroenterology, 26(4), 429-444 (2012-12-04) HCV treatment--no more room for interferonologists?Joost P H Drenth The New England journal of medicine, 368(20), 1931-1932 (2013-04-24) Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.E Rosenthal et al.HIV medicine, 16(4), 230-239 (2014-12-20) Synthesis and anti-influenza virus activity of 4-oxo- or thioxo-4,5-dihydrofuro[3,4-c]pyridin-3(1H)-ones.Ye Jin Jang et al.Antiviral research, 107, 66-75 (2014-05-06) My treatment approach to chronic hepatitis C virus.Mitchell L Shiffman et al.Mayo Clinic proceedings, 89(7), 934-942 (2014-05-29) Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors.Suria Marlina et al.Parasites & vectors, 8, 579-579 (2015-11-11) Derivation of Phase 3 dosing for peginterferon lambda-1a in chronic hepatitis C, Part 1: Modeling optimal treatment duration and sustained virologic response rates.Xiaodong Wang et al.Journal of clinical pharmacology, 55(1), 63-72 (2014-07-22) Eleganketal A, a highly oxygenated dibenzospiroketal from the marine-derived fungus Spicaria elegans KLA03.Yepeng Luan et al.Journal of natural products, 77(7), 1718-1723 (2014-06-27) Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.Ling-Fei Li et al.Gene, 544(2), 101-106 (2014-05-06) [Inosine triphosphatase gene polymorphism and ribavirin-related anemia in chronic hepatitis C patients].Jun-xia Geng et al.Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 20(12), 958-960 (2013-04-10) Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma.Ching-Sheng Hsu et al.Scientific reports, 5, 9954-9954 (2015-05-13) Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting.Jennifer C Price et al.Digestive diseases and sciences, 59(12), 3043-3052 (2014-08-12) Sofosbuvir and ribavirin for hepatitis C in patients with HIV coinfection.Mark S Sulkowski et al.JAMA, 312(4), 353-361 (2014-07-20) Cost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.Alena M Pfeil et al.PloS one, 10(5), e0126984-e0126984 (2015-05-15) Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4.Olfat Shaker et al.Mediators of inflammation, 2013, 392746-392746 (2013-04-12) When do psychiatric side effects emerge during antiviral treatment of hepatitis C?Gábor Gazdag et al.Psychiatria Danubina, 25(4), 398-400 (2013-11-20) Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.Tung-Hung Su et al.Proceedings of the National Academy of Sciences of the United States of America, 110(19), 7844-7849 (2013-04-25) Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: case report and literature review.Wenxue Zhao et al.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 18(1), 110-113 (2013-10-15) Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico.Lilliana Morales-Vásquez et al.Puerto Rico health sciences journal, 33(4), 177-183 (2015-01-08) Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial.K Rajender Reddy et al.The Lancet. Infectious diseases, 15(1), 27-35 (2014-12-09) The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitro.Rima Kulkarni et al.Antimicrobial agents and chemotherapy, 58(10), 6145-6150 (2014-08-06) Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.Phillip C Delekta et al.Journal of virology, 88(19), 11199-11214 (2014-07-18) [Hepatitis C virus-related cryoglobulinemic vasculitis with renal involvement: current possibilities of treatment].N B Gordovskaia et al.Terapevticheskii arkhiv, 85(6), 78-84 (2013-07-23) Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.Rajesh Panigrahi et al.Journal of virology, 89(1), 626-642 (2014-10-24) Natural cytotoxicity receptor-dependent natural killer cytolytic activity directed at hepatitis C Virus (HCV) is associated with liver inflammation, African American race, IL28B genotype, and response to pegylated interferon/ribavirin therapy in chronic HCV infection.Qinglai Meng et al.The Journal of infectious diseases, 209(10), 1591-1601 (2013-12-05) When will resistance be futile?Katherine L B Borden Cancer research, 74(24), 7175-7180 (2014-12-06) Sofosbuvir treatment in the pre and post liver transplantation phase: the sooner, the better.Alessio Aghemo et al.Gastroenterology, 148(1), 13-16 (2014-12-03) Hepatitis C treatment in dialysis patients: is a new dawn approaching?Craig E Gordon et al.American journal of kidney diseases : the official journal of the National Kidney Foundation, 64(2), 178-180 (2014-05-07) ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection.Pietro Andreone et al.Gastroenterology, 147(2), 359-365 (2014-05-14) Therapeutic potential of and treatment with boceprevir/telaprevir-based triple-therapy in HIV/chronic hepatitis C co-infected patients in a real-world setting.Mattias Mandorfer et al.AIDS patient care and STDs, 28(5), 221-227 (2014-05-07) Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.Valerianna K Amorosa et al.HIV clinical trials, 14(6), 274-283 (2013-12-18) Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection.Nezam Afdhal et al.The New England journal of medicine, 370(20), 1889-1898 (2014-04-15) Characterization of a respiratory syncytial virus L protein inhibitor.Choi-Lai Tiong-Yip et al.Antimicrobial agents and chemotherapy, 58(7), 3867-3873 (2014-04-30) Novel therapeutic approaches for hepatitis C.J S Au et al.Clinical pharmacology and therapeutics, 95(1), 78-88 (2013-10-16) Effect of ribavirin on subacute sclerosing panencephalitis virus infections in hamsters.Y Honda et al.Antimicrobial agents and chemotherapy, 38(4), 653-655 (1994-04-01) Remission of HCV-associated glomerulonephritis with pegylated ifn and ribavirin therapy after liver transplantation: case report and literature review.Maria Francesca Donato et al.The International journal of artificial organs, 36(1), 63-68 (2013-01-03) Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.Marina B Klein et al.HIV clinical trials, 15(4), 161-175 (2014-08-22) Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro.Filippo Dragoni et al.Antiviral research, 175, 104708-104708 (2020-01-14) Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models.Neil Mathias et al.The AAPS journal, 17(4), 988-998 (2015-05-03) [Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].Jean-Yves Nau Revue medicale suisse, 9(392), 1394-1395 (2013-07-26) The accuracy and cost-effectiveness of hepatitis C core antigen assay in the monitoring of anti-viral therapy in patients with chronic hepatitis C genotype 4.S M Kamal et al.Alimentary pharmacology & therapeutics, 42(3), 307-318 (2015-05-29) Regional disparities in interferon therapy for chronic hepatitis C in Japan: a nationwide retrospective cohort study.Naohiko Masaki et al.BMC public health, 15, 566-566 (2015-06-20) What the infectious disease physician needs to know about pegylated interferon and ribavirin.Naveen Gara et al.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56(11), 1629-1636 (2013-02-23) Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.Anuoluwapo Osinusi et al.JAMA, 310(8), 804-811 (2013-08-29) Editorial: can we afford the new direct-acting anti-virals for treatment of genotype 1 hepatitis C? Authors' reply.S Saab et al.Alimentary pharmacology & therapeutics, 40(8), 984-985 (2014-09-18) Section 13. Short-course pretransplant antiviral therapy is a feasible and effective strategy to prevent hepatitis C recurrence after liver transplantation in genotype 2 patients.Chih-Che Lin et al.Transplantation, 97 Suppl 8, S47-S53 (2014-05-23) Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication.Ilaria Vicenti et al.SLAS discovery : advancing life sciences R & D, 25(5), 506-514 (2020-03-19) Polymorphisms of Toll-like receptors 2 and 4 in chronically infected hepatitis C patients from north-east Croatia.Magdalena Perić et al.Archives of virology, 160(1), 297-304 (2014-11-20) Letter to the editor concerning the paper: Boltjes A, Op den Brouw ML, Biesta PJ, et al. Assessment of the effect of ribavirin on myeloid and plasmacytoid dendritic cells during interferon-based therapy of chronic hepatitis B patients [Molecular Immunology 53(1/2) (2013) 72-78].Ioannis Pachiadakis et al.Molecular immunology, 56(1-2), 129-130 (2013-06-05) HCV, ribavirin, and anemia: a new dawn.Stanislas Pol Gastroenterology, 145(5), 930-933 (2013-09-26) Therapy of hepatitis C--back to the future.T Jake Liang et al.The New England journal of medicine, 370(21), 2043-2047 (2014-05-06) ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.Fred Poordad et al.The New England journal of medicine, 370(21), 1973-1982 (2014-04-15) Antiviral treatment of hepatitis C.Eoin R Feeney et al.BMJ (Clinical research ed.), 348, g3308-g3308 (2014-07-09) Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.Nicolas Flori et al.Drugs, 73(3), 263-277 (2013-02-26) Contribution of CNT1 and ENT1 to ribavirin uptake in human hepatocytes.Min-Koo Choi et al.Archives of pharmacal research, 38(5), 904-913 (2014-07-12) Predictors of Pegylated Interferon Alpha and Ribavirin Efficacy and Long-Term Assessment of Relapse in Patients With Chronic Hepatitis C: A One-Center Experience From China.Qin Wu et al.Hepatitis monthly, 15(6), e28836-e28836 (2015-08-20) Replication of hepatitis C virus in peripheral blood mononuclear cells in patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.Malgorzata Inglot et al.Postepy higieny i medycyny doswiadczalnej (Online), 67, 186-191 (2013-04-27) Hepatitis C treatment options improving. Mayo Clinic health letter (English ed.), 31(1), 4-4 (2013-04-10) Interferon-free hepatitis C treatment: one pill to fit all?Margaret E Hellard et al.Lancet (London, England), 383(9916), 491-492 (2013-11-12) In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.Andrea D Branch et al.The American journal of clinical nutrition, 98(2), 423-429 (2013-06-07) Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus.Yoshihiko Tachi et al.PloS one, 10(7), e0133515-e0133515 (2015-07-28) Hepatitis C genotype 3: a tough match for interferon-free regimens.Alessio Aghemo et al.Gastroenterology, 146(4), 1125-1127 (2014-02-26) High-Dose Ribavirin Enhances Early Virological Response in Hepatitis C Genotype 1-Infected Patients.Karin Lindahl et al.Therapeutic drug monitoring, 37(6), 745-750 (2015-03-27) The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome.Joanna Jabłońska et al.BMC infectious diseases, 15, 556-556 (2015-12-08) Boceprevir for HCV in patients with HIV: where next?Anuoluwapo Osinusi et al.The Lancet. Infectious diseases, 13(7), 563-564 (2013-06-19) Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysis.Monica Basso et al.HIV clinical trials, 14(4), 127-139 (2013-08-09) In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor.Tse-I Lin et al.Antimicrobial agents and chemotherapy, 53(4), 1377-1385 (2009-01-28) National trends in prescription drug expenditures and projections for 2015.Glen T Schumock et al.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 72(9), 717-736 (2015-04-16) [Chronic hepatitis C. Interferon free therapy also in patients with liver cirrhosis]. MMW Fortschritte der Medizin, 156(21-22), 97-97 (2015-01-23) ABT-450/r-ombitasvir and dasabuvir with or without ribavirin for HCV.Peter Ferenci et al.The New England journal of medicine, 370(21), 1983-1992 (2014-05-06) Ribavirin Inhibits Parrot Bornavirus 4 Replication in Cell Culture.Jeffrey M B Musser et al.PloS one, 10(7), e0134080-e0134080 (2015-07-30) Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.Rym Benmously Mlika et al.International journal of dermatology, 52(5), 643-644 (2012-10-11) Summaries for patients. Pegylated interferon with or without ribavirin for patients with hepatitis C receiving hemodialysis. Annals of internal medicine, 159(11), I-14 (2013-12-04) Hepatocellular carcinoma after sustained viral response to interferon and ribavirin therapy in cirrhosis secondary to chronic hepatitis C.Nasir Khokhar et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 23(10), 699-702 (2013-10-12) An integrated biological approach to guide the development of metal-chelating inhibitors of influenza virus PA endonuclease.Annelies Stevaert et al.Molecular pharmacology, 87(2), 323-337 (2014-12-06) Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction.Gerson Dierley Keppeke et al.Journal of genetics and genomics = Yi chuan xue bao, 42(6), 287-299 (2015-07-15) Reply: To PMID 24519039.Martin Lagging et al.Hepatology (Baltimore, Md.), 60(6), 2130-2131 (2014-03-05) Induction of cytoplasmic rods and rings structures by inhibition of the CTP and GTP synthetic pathway in mammalian cells.Wendy C Carcamo et al.PloS one, 6(12), e29690-e29690 (2012-01-06) The rapid evolution of treatment strategies for hepatitis C.Andrew J Muir The American journal of gastroenterology, 109(5), 628-635 (2014-04-16) Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.Ann E Tollefson et al.Antiviral research, 112, 38-46 (2014-12-03) IFNL4-ΔG genotype is associated with slower viral clearance in hepatitis C, genotype-1 patients treated with sofosbuvir and ribavirin.Eric G Meissner et al.The Journal of infectious diseases, 209(11), 1700-1704 (2013-12-25) Variants of the inosine triphosphate pyrophosphatase gene and relapse risk following treatment for HCV genotype 2/3.Chia-Yen Dai et al.Hepatology (Baltimore, Md.), 60(6), 2129-2130 (2014-03-05) Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis.Eric Druyts et al.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 56(7), 961-967 (2012-12-18) Optimizing ribavirin exposure by therapeutic drug monitoring improves treatment response in patients with chronic hepatitis C genotype 1.Felix Stickel et al.The American journal of gastroenterology, 108(7), 1176-1178 (2013-07-04) Vitamin D levels in Egyptian HCV patients (genotype 4) treated with pegylated interferon.A A Mohamed et al.Acta gastro-enterologica Belgica, 76(1), 38-44 (2013-05-09) Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediates.Kym Lowry et al.PLoS pathogens, 10(6), e1004191-e1004191 (2014-06-20) Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.Jodi Dufner-Beattie et al.Antimicrobial agents and chemotherapy, 58(6), 3399-3410 (2014-04-09) Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.Chen-Hua Liu et al.Gut, 64(2), 303-311 (2014-04-22) Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.Ira M Jacobson et al.The New England journal of medicine, 368(20), 1867-1877 (2013-04-24) Simultaneous splenectomy during liver transplantation augments anti-viral therapy in patients infected with hepatitis C virus.Heng-Cheng Chu et al.American journal of surgery, 209(1), 180-186 (2014-06-15) Age-related increases in basal ganglia glutamate are associated with TNF, reduced motivation and decreased psychomotor speed during IFN-alpha treatment: Preliminary findings.Ebrahim Haroon et al.Brain, behavior, and immunity, 46, 17-22 (2014-12-17) Tangeretin from Citrus reticulate Inhibits Respiratory Syncytial Virus Replication and Associated Inflammation in Vivo.Jiao-Jiao Xu et al.Journal of agricultural and food chemistry, 63(43), 9520-9527 (2015-10-16) Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.Kris V Kowdley et al.The New England journal of medicine, 370(3), 222-232 (2014-01-17) All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.Michael Manns et al.Lancet (London, England), 384(9954), 1597-1605 (2014-08-01) Arenaviruses and lethal mutagenesis. Prospects for new ribavirin-based interventions.Héctor Moreno et al.Viruses, 4(11), 2786-2805 (2012-12-04) Practical silyl protection of ribonucleosides.Thomas P Blaisdell et al.Organic letters, 15(18), 4710-4713 (2013-09-05) Effect of Gender on the Response to Hepatitis C Treatment in an Inner-City Population.Priya Simoes et al.Women's health issues : official publication of the Jacobs Institute of Women's Health, 25(3), 289-293 (2015-05-13) Reversal of the antiviral activity of ribavirin against Sindbis virus in Ae. albopictus mosquito cells.H J Liao et al.Antiviral research, 22(4), 285-294 (1993-12-01) Development of biodegradable nanoparticles for liver-specific ribavirin delivery.Tsutomu Ishihara et al.Journal of pharmaceutical sciences, 103(12), 4005-4011 (2014-10-23) [Nucleosides of 1,2,4-triazole: potentialities and restrictions of chemo-enzymatic method for synthesis].I D Konstantinova et al.Bioorganicheskaia khimiia, 39(1), 61-80 (2013-07-13) Generation and characterization of influenza A viruses with altered polymerase fidelity.Peter P H Cheung et al.Nature communications, 5, 4794-4794 (2014-09-04) Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules.O Ferraris et al.Antiviral research, 118, 75-81 (2015-03-24) Shortened peginterferon and ribavirin treatment for chronic hepatitis C.Debbie Hartwell et al.International journal of technology assessment in health care, 28(4), 398-406 (2012-09-22) Understanding the effect of the HCV polymerase inhibitor mericitabine on early viral kinetics in the phase 2 JUMP-C and PROPEL studies.Ya-Chi Chen et al.British journal of clinical pharmacology, 78(3), 533-542 (2014-03-08) End of treatment response in chronic hepatitis C patients treated with interferon alpha and ribavirin.Amjad Tanveer et al.Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 23(10), 764-765 (2013-10-12) Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.Lior H Katz et al.The Cochrane database of systematic reviews, 9(9), CD008516-CD008516 (2012-09-14) Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study.Thomas Berg et al.Liver international : official journal of the International Association for the Study of the Liver, 35(2), 448-454 (2014-10-17) Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsers.Wattana Sukeepaisarnjaroen et al.World journal of gastroenterology, 21(28), 8660-8669 (2015-08-01)

备注